Literature DB >> 29191294

Evolving Areas in Heart Transplantation.

Brittany N Weber1, Jon A Kobashigawa2, Michael M Givertz3.   

Abstract

It has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967 in South Africa. Remarkable progress has been made since that time, including changes in surgical techniques, immunosuppression, donor and recipient selection, and post-transplant care. In this paper, we provide a perspective on the changing face of heart transplantation and highlight key evolving areas. Topics that are covered include advances in immunosuppression, screening for acute and chronic rejection, cardiac allograft vasculopathy, and ongoing advancements in cardiac replacement therapy, including xenotransplantation, stem-cell research, tissue engineering, and the total artificial heart.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac allograft vasculopathy; heart transplantation; immunosuppression; stem cells; tissue engineering; transplant rejection

Mesh:

Year:  2017        PMID: 29191294     DOI: 10.1016/j.jchf.2017.10.009

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  9 in total

1.  Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients.

Authors:  C Sciaccaluga; G E Mandoli; N Sisti; M B Natali; A Ibrahim; D Menci; A D'Errico; G Donati; G Benfari; S Valente; S Bernazzali; M Maccherini; S Mondillo; M Cameli; M Focardi
Journal:  Int J Cardiovasc Imaging       Date:  2021-01-13       Impact factor: 2.357

2.  Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation.

Authors:  Yuan Chang; Xiangjie Li; Qi Cheng; Yiqing Hu; Xiao Chen; Xiumeng Hua; Xuexin Fan; Menghao Tao; Jiangping Song; Shengshou Hu
Journal:  Basic Res Cardiol       Date:  2021-12-06       Impact factor: 17.165

3.  Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation.

Authors:  Chao Gao; Xiaodong Wang; Jian Lu; Zhilin Li; Haowen Jia; Minghao Chen; Yuchen Chang; Yanhong Liu; Peiyuan Li; Baotong Zhang; Xuezhi Du; Feng Qi
Journal:  Stem Cell Res Ther       Date:  2020-06-17       Impact factor: 6.832

4.  Artesunate Restrains Maturation of Dendritic Cells and Ameliorates Heart Transplantation-Induced Acute Rejection in Mice through the PERK/ATF4/CHOP Signaling Pathway.

Authors:  Yuanyang Chen; Sihao Zheng; Zhiwei Wang; Xin Cai; Yanjia Che; Qi Wu; Shun Yuan; Xiaohan Zhong
Journal:  Mediators Inflamm       Date:  2021-08-21       Impact factor: 4.711

5.  Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients.

Authors:  Arvind Bhimaraj; Sherif F Nagueh; Pimprapa Vejpongsa; Guillermo Torre-Amione; Hernan G Marcos-Abdala; Salil Kumar; Keith Youker
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

6.  Immune response in heart transplantation: a bibliometric analysis.

Authors:  Xueqin Zhang; Wei Liu; Yang Du
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

7.  Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection.

Authors:  Kang Luo; Lin Li; Mingyao Meng; Yan Chen; Zongliu Hou
Journal:  Ann Transplant       Date:  2022-03-29       Impact factor: 1.530

Review 8.  The Past, Present and Future of Heart Transplantation.

Authors:  In Cheol Kim; Jong Chan Youn; Jon A Kobashigawa
Journal:  Korean Circ J       Date:  2018-07       Impact factor: 3.243

9.  In-hospital outcomes after percutaneous coronary interventions in cardiac allograft recipients.

Authors:  Sakiru Oyetunji Isa; Olajide Buhari; Muminat Adeniran-Isa; Mahin Khan; Hafiz Khan; Raghunandan Konda; Hameem Changezi; Luis Afonso
Journal:  SAGE Open Med       Date:  2021-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.